Equine herpesvirus 1 has been endemic in horse populations worldwide for far longer than humans have been studying it, and eradication is not an option. There is only one correct response to the threat of EHV-1: from the national federation to the owner of a child’s pony, everyone in the horse industry must take personal responsibility to do their part to minimize the possibility of an outbreak, and take the appropriate steps when an outbreak inevitably happens.

A dangerous mutation

Researchers have learned that there are multiple strains of the EHV-1 virus. The type for which a vaccine currently exists is now generally known as the “wild strain,” whose most serious consequence is usually abortion, the primary purpose for the routine “rhino” vaccinations. In 2001, following two EHV-1 outbreaks in North America whose characteristics raised red flags in the veterinarian community, a previously unknown mutation of EHV-1 was identified. A disease that had been quietly in the background for generations was suddenly front and centre.

Dr. Peter Timoney of the Gluck Research Center at the University of Kentucky is considered one of the world’s foremost experts on infectious diseases in horses. The new strain, he says, has only a single point mutation, but it’s a mutation that has a powerful impact. “The mutation is directly involved in virus replication,” he explains. “It is more contagious.” The mutated strain has a much higher level of viremia (presence in the blood). It reaches a peak more quickly and lasts longer during that period, which means that an infected horse is shedding more virus for longer, making it more contagious. Additionally, this strain has a much higher clinical attack rate than the wild strain, and a mortality rate that Dr. Timoney says may be as high as 40%. “In outbreaks associated with a high clinical attack rate and neurological disease, 75% of those were associated with the strain with that single point mutation which controls replication.”

Advertisement